+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2013-06-25Number of Pages: 115

Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018

Global Stem Cells Market: Snapshot

The high unmet medical needs worldwide play a pivotal role in the tremendous growth of the global stem cells market. With the growing prevalence of chronic diseases and malignancies due to the changing lifestyles, stem cells are being highly acknowledged for their treatment. The increasing investments in the research and development of stem cells rendered by several governments worldwide are also augmenting the market. Moreover, the rising popularity of stem cells banking services and expanding medical tourism industry are providing a fillip to the market.

Despite the array of favorable factors, the market growth is hampered by the high cost of treatment. This factor is compounded by the lack of reimbursement policies, which is making stem cell treatment almost unaffordable for patients belonging to low and medium income groups. Furthermore, the increasing cases of unethical harvesting of stem cells are prompting governments to formulate stringent regulations, which in turn are adversely affecting the growth of the market. As per the findings of the report, the global stem cells market was valued at US$62.28 bn in 2015 and is estimated to rise to US$119.51 bn by 2018, expanding at a CAGR of 24.2% from 2012 to 2018.

Easy Harvesting Procedure of Adult Stem Cells to Promote their Adoption in Research Activities

On the basis of products, adult stem cells will continue to dominate the market until 2018, representing 86.0% of the overall market revenue. The procedures of harvesting adult stem cells are less complicated in adults. Moreover, better acceptance by the human body and lesser probability of contamination during the process of culture are leading to the higher adoption of adult stem cells in a multitude of research activities in the field of regenerative medicine. The induced pluripotent stem cells (iPSC) segment is anticipated to expand at an impressive CAGR of 25.3% during the forecast period.

On the basis of technology, cell acquisition will be the leading segment in terms of revenue in 2015. The acquisition is the foremost step undertaken in obtaining stem cells. The primary role of this step is warranting the leadership of the segment until 2018.

North America to Lead Revenue Generation through 2018

North America will be the leading regional market throughout the forecast period, accounting for 60% of the overall market revenue by 2018. Stem cell facilitates the treatment of certain type of cardiac diseases and neurological disorders which are highly prevalent in the region, particularly in the U.S. This coupled with the availability of only symptomatic treatment for these diseases is triggering the growth of the North America stem cell market. Moreover, looking at the immense benefits offered by stem cells, several governments and organizations are pouring funds into their research and marketing.

Asia Pacific is poised to rise at a CAGR of 25.7% during the same period. Companies involved in clinical research are shifting their base from developed countries to developing countries such as Hong Kong, Singapore, India, and China. This shift can be attributed to factors such as lower cost incurred in clinical trials and expanding pool of patients which makes the patient recruitment easier. Moreover, contract research organizations are increasing in these countries. These factors are, collectively, contributing to the growth of the region.

Some of the key players in the global stem cells market are Advanced Cell Technology, Angel Biotechnology, Bioheart, Biotime Inc., Brainstorm Cell Therapeutics, California Stem Cell Inc., Celgene Corporation Inc., Cellartis AB, Cellular Engineering Technologies, Cytori Therapeutics Inc., Osiris Therapeutics, and Stemcelltechnologies Inc.

Table of Content

 

Chapter 1 Preface

1.1 Report Description

1.2 Research Methodology

 

Chapter 2 Executive Summary

 

Chapter 3 Market Overview

3.1 Market Trends and Future Outlook

      3.1.1 Global Stem Cells Market, 2010 – 2018 (USD Billion)

3.2 Market Dynamics

      3.2.1 Market Drivers

               3.2.1.1 Unmet Medical Needs

               3.2.1.2 Increasing Government Support

               3.2.1.3 Growing Medical Tourism

               3.2.1.4 Rising Stem Cells Banking Services

               3.2.1.5 Impact Analysis of the Market Drivers

     3.2.2 Market Restraints

               3.2.2.1 High Cost of Treatment

               3.2.2.2 Government Regulations against Unethical Harvesting of Stem Cells

               3.2.2.3 Impact Analysis of the Market Restraints

     3.2.3 Market Opportunities

               3.2.3.1 Rising Neurodegenerative Disease Patients

               3.2.3.2 Increasing Disposable Income in Emerging Nations

               3.2.3.3 Replacing Animal Tissue in Drug Discovery

               3.2.3.4 Growing Contract Research Industry

     3.2.4 Porter’s Five Forces Analysis for the Global Stem Cells Market

               3.2.4.1 Bargaining Power of Suppliers

               3.2.4.2 Bargaining Power of Buyers

               3.2.4.3 Threat of New Entrants

               3.2.4.4 Threat of Substitutes

      3.2.5 Competitive Rivalry

3.3 Market Attractiveness

      3.3.1 Market Attractiveness Analysis of the Global Stem Cells Market, By Geography

 

Chapter 4 Global Stem Cells Market, By Products

4.1 Market Segmentation: Global Stem Cells Market, By Products

4.2 Overview

4.3 Adult Stem Cells Market, 2010 – 2018 (USD Billion)

      4.3.1 Hematopoietic Stem Cells Market, 2010 – 2018 (USD Billion)

      4.3.2 Mesenchymal Stem Cells Market, 2010 – 2018 (USD Billion)

      4.3.3 Neuronal Stem Cells Market, 2010 – 2018 (USD Billion)

      4.3.4 Dental Stem Cells (Mesenchymal Stem Cells, Neuronal Stem Cells) Market, 2010 – 2018 (USD Billion)

      4.3.5 Umbilical Cord Stem Cells (Hematopoietic Stem Cells, Mesenchymal Stem Cells) Market, 2010 – 2018 (USD Billion)

4.4 Human Embryonic Stem Cells Market, 2010 – 2018 (USD Billion)

4.5 Induced Pluripotent Stem Cells Market, 2010 – 2018 (USD Billion)

4.6 Rat Neural Stem Cells Market, 2010 – 2018 (USD Billion)

4.7 Very Small Embryonic-Like Stem Cells Market, 2010 – 2018 (USD Billion)

 

Chapter 5 Global Stem Cells Market, By Technology

5.1 Market Segmentation: Global Stem Cells Market, By Technology

5.2 Overview

5.3 Global Stem Cell Acquisition Market, 2010 – 2018 (USD Billion)

      5.3.1 Global Bone Marrow Harvest for Stem Cells, 2010 – 2018 (USD Billion)

      5.3.2 Global Apheresis for Stem Cells Market, 2010 – 2018 (USD Billion)

      5.3.3 Global Umbilical Cord Blood Market, 2010 – 2018 (USD Billion)

5.4 Global Stem Cell Production Market, 2010 – 2018 (USD Billion)

      5.4.1 Global Therapeutic Cloning for Stem Cells Market, 2010 – 2018 (USD Billion)

      5.4.2 Global Stem Cells Production By In Vitro Fertilization Market, 2010 – 2018 (USD Billion)

      5.4.3 Global Stem Cell Isolation Market, 2010 – 2018 (USD Billion)

      5.4.4 Global Stem Cell Culture Market, 2010 – 2018 (USD Billion)

5.5 Global Stem Cell Cryopreservation Market, 2010 – 2018 (USD Billion)

5.6 Global Stem Cells Expansion and Sub-Culture Market, 2010 – 2018 (USD Billion)

 

Chapter 6 Global Stem Cells Market, By Application

6.1 Market Segmentation: Global Stem Cells Market, By Application

6.2 Overview

6.3 Global Stem Cells Market in Regenerative Medicine, 2010 – 2018 (USD Billion)

      6.3.1 Stem Cells Market in Neurology, 2010 – 2018 (USD Billion)

      6.3.2 Global Stem Cells Market in Orthopedics, 2010 – 2018 (USD Billion)

      6.3.3 Global Stem Cells Market in Oncology, 2010 – 2018 (USD Billion)

      6.3.4 Global Stem Cells Market in Hematology, 2010 – 2018 (USD Billion)

      6.3.5 Global Stem Cells Market for Cardiovascular and Myocardial Infarction, 2010 – 2018 (USD Billion)

      6.3.6 Global Stem Cells Market for Injuries, 2010 – 2018 (USD Billion)

               6.3.6.1 Global Stem Cells Market for Wound Care, 2010 – 2018 (USD Billion)

               6.3.6.2 Global Stem Cells Market for Spinal Cord Injuries, 2010 – 2018 (USD Billion)

               6.3.6.3 Global Stem Cells Market for Other (Joint Injuries, Eye Injuries, Lacerations and Concussions) Injuries, 2010 – 2018 (USD Billion)

      6.3.7 Global Stem Cells Market for Diabetes, 2010 – 2018 (USD Billion)

      6.3.8 Global Stem Cells Market for Liver Disorders, 2010 – 2018 (USD Billion)

      6.3.9 Global Stem Cells Market for Incontinence, 2010 – 2018 (USD Billion)

      6.3.10 Global Stem Cells Market for Other (Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder) Regenerative Medicine Applications, 2010 – 2018 (USD Billion)

6.4 Global Stem Cells Market in Drug Discovery and Development, 2010 – 2018 (USD Billion)

 

Chapter 7 Global Stem Cells Market, By Geography

7.1 Overview

7.2 North America

      7.2.1 North America Stem Cells Market, 2010–2018 (USD Billion)

7.3 Europe

      7.3.1 Europe Stem Cells Market, 2010–2018 (USD Billion)

7.4 Asia

      7.4.1 Asia Stem Cells Market, 2010–2018 (USD Billion)

7.5 Rest of the World (Row)

      7.5.1 Row Stem Cells Market, 2010–2018 (USD Billion)

 

Chapter 8 Competitive Landscape

8.1 Heat Map Analysis for the Key Market Players

      8.1.1 Advanced Cell Technology Inc.

      8.1.2 STEMCELL Technologies Inc.

      8.1.3 Cellular Engineering Technologies Inc.

      8.1.4 Biotime Inc.

      8.1.5 Cellartis AB

8.2 Business Strategies for Success

      8.2.1 Focus on Research and Development

      8.2.2 Partnerships, Collaborations and Acquisitions

 

Chapter 9 Company Profiles

9.1 Advanced Cell Technology

      9.1.1 Company Overview

      9.1.2 Financial Overview

      9.1.3 Business Strategies

      9.1.4 Product Portfolio

      9.1.5 Recent Developments

9.2 Angel Biotechnology

      9.2.1 Company Overview

      9.2.2 Financial Overview

      9.2.3 Business Strategies

      9.2.4 Product Portfolio

      9.2.5 Recent Developments

9.3 Bioheart

      9.3.1 Company Overview

      9.3.2 Financial Overview

      9.3.3 Product Portfolio

      9.3.4 Business Strategies

      9.3.5 Recent Developments

9.4 Brainstorm Cell Therapeutics

      9.4.1 Company Overview

      9.4.2 Financial Overview

      9.4.3 Business Strategies

      9.4.4 Product Portfolio

      9.4.5 Recent Developments

9.5 California Stem Cell Inc.

      9.5.1 Company Overview

      9.5.2 Product Portfolio

      9.5.3 Business Strategies

      9.5.4 Recent Developments

9.6 Celgene Corporation Inc.

      9.6.1 Company Overview

      9.6.2 Financial Overview

      9.6.3 Business Strategies

      9.6.4 Product Portfolio

      9.6.5 Recent Developments

9.7 Cellartis AB

      9.7.1 Company Overview

      9.7.2 Business Strategies

      9.7.3 Product Portfolio

      9.7.4 Recent Developments

9.8 Cellular Engineering Technologies

      9.8.1 Company Overview

      9.8.2 Business Strategies

      9.8.3 Product Portfolio

      9.8.4 Recent Developments

9.9 Cytori Therapeutics Inc.

      9.9.1 Company Overview

      9.9.2 Financial Overview

      9.9.3 Product Portfolio

      9.9.4 Business Strategies

      9.9.5 Recent Developments

9.10 Biotime Inc.

      9.10.1 Company Overview

      9.10.2 Financial Overview

      9.10.3 Product Portfolio

      9.10.4 Business Strategies

      9.10.5 Recent Developments

9.11 Osiris Therapeutics

      9.11.1 Company Overview

      9.11.2 Financial Overview

      9.11.3 Product Portfolio

      9.11.4 Business Strategies

      9.11.5 Recent Developments

9.12 Stemcelltechnologies Inc.

      9.12.1 Company Overview

      9.12.2 Financial Overview

      9.12.3 Business Strategies

      9.12.4 Product Portfolio

      9.12.5 Recent Developments

List of Figures 

 

FIG. 1 Global Stem Cells Market, By Product Types, 2011 (USD Billion)

FIG. 2 Global Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 3 Porter’s Five Forces Analysis for the Global Stem Cells Market

FIG. 4 Market Attractiveness Analysis of the Stem Cells Market, By Geography

FIG. 5 Market Segmentation: Global Stem Cells Market, By Products

FIG. 6 Comparative Analysis of The Stem Cells Market, By Products, 2011 & 2018 (%)

FIG. 7 Comparative Analysis of Adult Stem Cells Market, By Products, 2011 & 2018 (%)

FIG. 8 Global Hematopoietic Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 9 Global Mesenchymal Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 10 Global Neuronal Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 11 Global Dental Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 12 Global Umbilical Cord Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 13 Global Human Embryonic Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 14 Global Induced Pluripotent Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 15 Global Rat Neural Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 16 Global Very Small Embryonic-Like Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 17 Market Segmentation: Global Stem Cells Market, By Technology

FIG. 18 Comparative Analysis of the Global Stem Cells Market, By Technology, 2011 & 2018 (%)

FIG. 19 Comparative Analysis of the Global Cell Acquisition Market, By Procedure, 2011 & 2018 (%)

FIG. 20 Global Bone Marrow Harvest for Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 21 Global Apheresis for Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 22 Global Umbilical Cord Blood Market, 2010 – 2018 (USD Billion)

FIG. 23 Comparative Analysis of the Stem Cell Production Market, By Procedures, 2011 & 2018 (%)

FIG. 24 Global Therapeutic Cloning for Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 25 Global Stem Cells Production By In Vitro Fertilization Market, 2010 – 2018 (USD Billion)

FIG. 26 Global Stem Cell Isolation Market, 2010 – 2018 (USD Billion)

FIG. 27 Global Stem Cell Culture Market, 2010 – 2018 (USD Billion)

FIG. 28 Global Stem Cell Cryopreservation Market, 2010 – 2018 (USD Billion)

FIG. 29 Global Stem Cells Expansion and Sub-Culture Market, 2010 – 2018 (USD Billion)

FIG. 30 Market Segmentation: Global Stem Cells Market, By Application

FIG. 31 Comparative Analysis of the Global Stem Cells Market, By Application, 2011 & 2018 (%)

FIG. 32 Comparative Analysis of Global Stem Cells Market in Regenerative Medicine, By Applications, 2011 & 2018 (%)

FIG. 33 Global Stem Cells Market in Neurology, 2010 – 2018 (USD Billion)

FIG. 34 Global Stem Cells Market in Orthopedics, 2010 – 2018 (USD Billion)

FIG. 35 Global Stem Cells Market in Oncology, 2010 – 2018 (USD Billion)

FIG. 36 Global Stem Cells Market in Hematology, 2010 – 2018 (USD Billion)

FIG. 37 Global Stem Cells Market for Cardiovascular and Myocardial Infarction, 2010 – 2018 (USD Billion)

FIG. 38 Comparative Analysis of Global Stem Cells in Injuries Market, 2011 & 2018 (%)

FIG. 39 Global Stem Cells Market for Wound Care, 2010 – 2018 (USD Billion)

FIG. 40 Global Stem Cells Market for Spinal Cord Injuries, 2010 – 2018 (USD Billion)

FIG. 41 Global Stem Cells Market for Other Injuries, 2010 – 2018 (USD Billion)

FIG. 42 Global Stem Cells in Diabetes Market, 2010 – 2018 (USD Billion)

FIG. 43 Global Stem Cells Market for Liver Disorders, 2010 – 2018 (USD Billion)

FIG. 44 Global Stem Cells Market for Incontinence, 2010 – 2018 (USD Billion)

FIG. 45 Global Stem Cells Market for Other Regenerative Medicine Applications, 2010 – 2018 (USD Billion)

FIG. 46 Global Stem Cells in Drug Discovery and Development Market, 2010 – 2018 (USD Billion)

FIG. 47 Comparative Analysis of the Global Stem Cells Market, By Geography, 2011 & 2018 (%)

FIG. 48 North America Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 49 Europe Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 50 Asia Stem Cells Market, 2010 – 2018 (USD Billion)

FIG. 51 Row Stem Cells Market, 2010 –2018 (USD Billion)

FIG. 52 Heat Map Analysis: Global Stem Cells Market

FIG. 53 Annual Sales of Advanced Cell Technology, 2009 – 2011 (USD Million)

FIG. 54 Annual Revenue of Angel Biotechnology, 2009 – 2011 (USD Million) (Conversion Rate: 1 GBP =1 .52 USD)

FIG. 55 Annual Sales of Bioheart Inc., 2009 – 2011 (USD)

FIG. 56 Annual Revenue of Celgene Corporation Inc., 2009 – 2011 (USD Million)

FIG. 58 Annual Sales of Biotime Inc, 2009 – 2011 (USD Million)

FIG. 60 Annual Sales of Neostem Inc., 2009 – 2011 (USD Million)

List of Tables

 

TABLE 1 Market Snapshot: Global Stem Cells Market

TABLE 2 Global Stem Cells Market, By Products, 2010 – 2018 (USD Billion)

TABLE 3 Impact Analysis of the Market Drivers for Stem Cells Market

TABLE 4 Impact Analysis of the Market Restraints for Stem Cells Market

TABLE 5 Global Adult Stem Cells Market, By Products, 2010 – 2018 (USD Billion)

TABLE 6 Global Stem Cells Market, By Technology, 2010 – 2018 (USD Billion)

TABLE 7 Global Cell Acquisition Market, By Procedure, 2010 – 2018 (USD Billion)

TABLE 8 Global Stem Cells Market In Regenerative Medicine, By Applications, 2010 – 2018 (USD Billion)

TABLE 9 Global Stem Cells Market for Injuries, By Applications, 2010 – 2018 (USD Billion)

TABLE 10 Global Stem Cells Market, By Geography, 2010–2018 (USD Billion)

Stem Cells Market: Overview

The rising funding from numerous governments and private organizations globally and the rising inclination toward stem cell research are amongst the prime factors boosting the growth of the global stem cells market. The emergence of numerous stem cell therapies also represent huge development opportunities for the key players in the stem cells market. In addition, the increasing demand for regenerative treatment options globally will positively impact the growth of the overall market.

The report makes use of various analysis tools such as SWOT analysis and Porter’s five forces analysis in order to present a comprehensive understanding of all the attributes related to the market. A thorough review of the market forces impeding and propelling the growth of the stem cells market also forms an integral part of this study. Furthermore, a vividly defined growth map of the market in terms of technological evolution is presented through this study.

This report presents a comprehensive overview of the global stem cells market as well as its related technologies. It also deploys an in-depth understanding of the strategies adopted by the players specializing within this field in order to meet the growing challenges of a fast-growing and competitive market. The strengths and weaknesses of these players have also been presented in this study.

Stem Cells Market: Drivers and Restraints

The global stem cells market is fuelled by the advancement of medical tourism industry and the increasing therapeutic research activities globally. In addition, the increasing stem cell banking services will positively impact the development of the overall market. Furthermore, the growing medical requirements of individuals in a number of nations will raise the demand for stem cells, hence boosting market development.

The increasing disposable income of individuals, particularly in emerging economies and the evolving contract research industry will bring in new opportunities in this market. In addition, the increasing count of patients having neurodegenerative diseases will also propel the demand for stem cells. Stems cells are also substituting animal tissues in drug delivery. This is another key growth opportunity in the market for stem cells.

However, the skyrocketing treatment costs involved in the usage of stem cells may impede the growth of the stem cells market. In addition, the increasing regulations imposed by governments in various nations globally on stem cells’ unethical harvesting may negatively impact the growth of the global stem cells market.

Stem Cells Market: Region-wise Outlook

In terms of geography, the stem cells market is categorized into Europe, Asia, North America, and Rest of the World (RoW). Of these, North America led the market in the past and was trailed by the region of Europe. The reason for the dominance of North America is that stem cells present therapeutic solutions for highly prevalent diseases in the U.S. such as neurological and cardiac disorders.

In addition, a number of grants given by organizations such as National Institute of Health (NIH), New York Stem Cell Science, and California Institute for Regenerative Medicine (CIRM) have encouraged research institutes to invest in the research activities for stem cells, thus bolstering market growth in North America.

On the other hand, Asia is predicted to exhibit a double digit growth rate in the coming years due to the booming contract research outsourcing market and the constantly evolving medical tourism industry in this region.

Key players Mentioned in the Report are:

The leading players in the global stem cells market are STEMCELL Technologies Inc., Cellular Engineering Technologies, Biotime Inc., Celgene Corporation Inc., Bioheart, Brainstorm Cell Therapeutics, Osiris Therapeutics, Cellartis AB, Cytori Therapeutics Inc., California Stem Cells Inc., Advanced Cell Technology Inc., and Angel Biotechnology, amongst others.

Major regions analyzed under this research report are: 

  • North America 
  • Asia
  • Europe
  • Rest of the World  

This report gives you access to decisive data such as:

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years

Key highlights of this report:

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments


 
 
Back To Top